Mark Wilkinson

MB, ChB, PhD, FRCS

Department of Oncology and Metabolism

Professor of Orthopaedics

Mark Wilkinson Staff
j.m.wilkinson@sheffield.ac.uk
+44 114 215 9029

Full contact details

Mark Wilkinson
Department of Oncology and Metabolism
EU14, E Floor
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

Career history

  • 1991 MBChB University of Sheffield
  • 1991-1996 Basic Surgical Training, Royal Hallamshire Hospital, Sheffield
  • 1996 FRCS Royal College of Surgeons (Eng)
  • 1996-2006 Higher Surgical Training North Trent HST Program
  • 2002 PhD University of Sheffield
  • 2004 FRCS (Ortho) Royal College of Surgeons (Eng)
  • 2006 Consultant Orthopaedic Surgeon, Stockport
  • 2007 HEFCE Clinical Senior Lecturer, University of Sheffield
  • 2007 Honorary Consultant in Orthopaedics, Sheffield Teaching Hospitals
  • 2012 Professor of Orthopaedics, University of Sheffield
Research interests
  • Joint arthroplasty mechanisms of failure
  • Cytokine genetics
  • Metabolic bone disease
  • Novel biological therapies for osteolysis
  • Surrogate outcome markers for implant performance and failure
  • Clinical outcomes measurement after THA
  • Genetics of bone shape and remodelling responses to disease
  • Genetics of osteoarthritis
  • Effects of metal ion exposure on bone and other organ systems
Publications

Journal articles

Chapters

Conference proceedings papers

Grants
  • National Institutes of Health Research
  • Arthritis Research UK
  • Clinical Research Fellow (Jan 2000 – Oct 2001)
  • John Charnley Trust
  • Clinical Research Fellow (Jan 1999 – Dec 1999)
  • Royal College of Surgeons of England
  • Laming-Evans Clinical Research Fellow (Jan 1998 – Dec1998)
  • Advanced Clinical Training Fellowships:
  • 2006 Cavendish Hip Fellow, Northern General Hospital, Sheffield
  • 2005 International Arthroplasty Fellow, Wrightington Hospital, Wigan, Lancs
  • 2005 Zurich, Switzerland (arthroplasty)
  • 2005 Toronto, Canada (revision arthroplasty)
  • 2003 Multiple centres Japan, (rheumatoid surgery)

Principal funding sources

  • Versus Arthritis 
  • National Institutes for Health Research
  • Medical Research Council
  • Charity
  • Industry